why choose us

300×250 Ad Slot

Research Article: Delivery of Plasmid DNA by Ionizable Lipid Nanoparticles to Induce CAR Expression in T Cells

Date Published: 2023-10-18

Introduction:
Immunotherapy, using T cells expressing the chimeric antigen receptor (CAR) targeting CD, has been approved since by the FDA for the treatment of B-cell acute lymphoblastic leukemia (B-ALL), , and later for large B-cell lymphoma (BCL) and multiple myeloma (MM). , Due to the high remission rates obtained by this treatment, CAR T cells are a useful and efficient approach for the treatment of hematologic cancers. , Despite its specificity, they are still inaccessible to many patients due to the high cost of available…

Read more

300×250 Ad Slot